Posts by: Admin

News

In a recent study titled “Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate”, published in PLOS Computational Biology, a research team led by Karl Griswold, Ph.D., ... Read more

January 28, 2015

Novel Protein Fusion Therapy Effective Against Resistant Leukemia

News

In a new study published in the Journal of Clinical Investigation, a research team from the Children’s Hospital Los Angeles (CHLA) designed a new protein-based therapy that may be extremely ... Read more

January 20, 2015

New Imaging Technique Allows Real-Time Tracking Of Immune Cells

News

In a recent study titled “64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET”, published in the Proceedings of the National Academy ... Read more

January 19, 2015January 19, 2015

Intrexon, ZIOPHARM, and MD Anderson Collaborate In CAR T Cells Immunotherapy

News

Intrexon Corporation has announced, together with ZIOPHARM Oncology, the signing of an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center for the development of non-viral adoptive cellular cancer immunotherapies. ... Read more

January 16, 2015January 16, 2015

New Phase I Clinical Trial To Test CAR T Cell Therapy

News

Cancer fighting chimeric antigen receptor (CAR) T cells, developed by Dr. Charles Sentman’s laboratory of Dartmouth’s Norris Cotton Cancer Center, are now entering a Phase I clinical trial. CAR-T cells ... Read more

January 13, 2015January 13, 2015

Celsion Submits Clinical Protocol to The FDA For its GEN-1 Immunotherapy

News

Celsion Corporation has announced the submission of its Phase I clinical trial protocol to the U.S. Food and Drug Administration (FDA) for GEN-1, a DNA-based immunotherapy for cancer treatment. The protocol ... Read more

January 12, 2015January 12, 2015

Bacteria Contribute to Development of Skin Cancer

News

A recent study, published in Nature Communications by King’s College London researchers, has identified a novel mechanism associated with skin damage that initiates tumor formation. The researchers describe an innate ... Read more

January 7, 2015January 7, 2015

Amgen And Kite Pharma Will Jointly Develop T Cell Immunotherapy

News

A recent strategic agreement was recently announced by Amgen and Kite Pharma, with the goal to develop and commercialize new Chimeric Antigen Receptor (CAR) T-cell immunotherapies. These engineered T cells ... Read more

January 6, 2015January 6, 2015

Researchers Receive Grant to Develop Novel Immunotherapy Treatment For Neuroblastoma

News

Alex’s Lemonade Stand, a nonprofit organization, has awarded the Bio-therapeutics Impact Award to three individuals, including Baylor College of Medicine and Texas Children’s Cancer Center researcher, Dr. Leonid Metelitsa. Dr. ... Read more

January 5, 2015January 5, 2015

Conkwest Appoints New Co-Chairman And Receives $50m Investment For Development of Immunotherapies

News

Conkwest, Inc., a company developing the proprietary immunotherapeutic Natural Killer (NK) cell-line platform, Neukoplast (NK-92), has announced that physician scientist Dr. Patrick Soon-Shiong, NantWorks founder, has agreed to acquire almost $48 ... Read more

Posts by: Admin

admin

Researchers Test Deimmunized Biotherapeutic Agents

Novel Protein Fusion Therapy Effective Against Resistant Leukemia

New Imaging Technique Allows Real-Time Tracking Of Immune Cells

Intrexon, ZIOPHARM, and MD Anderson Collaborate In CAR T Cells Immunotherapy

New Phase I Clinical Trial To Test CAR T Cell Therapy

Celsion Submits Clinical Protocol to The FDA For its GEN-1 Immunotherapy

Bacteria Contribute to Development of Skin Cancer

Amgen And Kite Pharma Will Jointly Develop T Cell Immunotherapy

Researchers Receive Grant to Develop Novel Immunotherapy Treatment For Neuroblastoma

Conkwest Appoints New Co-Chairman And Receives $50m Investment For Development of Immunotherapies